Doctor profile · Federal record
Dr. Larry Broadwell, MD
Rheumatology Physician (CMS: Rheumatology) · Shreveport, LA
- NPI 1326194036
- Accepts Medicare
- MIPS 89.9 / 100 · 2023
- 50 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
820 Jordan St, Suite 201
Shreveport, LA 711014518
(318) 221-0399
fax (318) 221-1940
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- November 16, 2007
- Year of graduation
- 1976 — 50 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Louisiana #013598
- Medicaid
- LA #1303429
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1326194036. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
385,220
Distinct HCPCS
10
Medicare allowed
$6,272,449
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 177,406 | 341 | $13 | |
J3262 |
Injection, tocilizumab, 1 mg | 55,767 | 22 | $6 | |
J0897 |
Injection, denosumab, 1 mg | 45,007 | 533 | $23 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 37,000 | 38 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 27,233 | 92 | $42 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 25,200 | 50 | $10 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 2,541 | 16 | $33 | |
J9312 |
Injection, rituximab, 10 mg | 2,405 | 13 | $80 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 1,541 | 487 | $116 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 1,180 | 608 | $65 |
In context: peer comparison
Among 5 peers in Shreveport Rheumatology Physician, average services per provider: 3,868. This provider delivers 100× the peer median.Open Payments
Industry payments received
All-time total
$5,034
Transactions
206
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 79 | $1,294.16 | |
| Abbvie INC. | 24 | $873.53 | |
| Novartis Pharmaceuticals Corporation | 20 | $434.27 | |
| Mallinckrodt Hospital Products INC. | 16 | $380.97 | |
| Janssen Biotech, INC. | 8 | $335.72 | |
| GlaxoSmithKline, LLC. | 9 | $239.52 | |
| Ucb, INC. | 11 | $221.60 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $158.44 | |
| Scilex Pharmaceuticals INC. | 4 | $137.64 | |
| US Oncology Corporate, INC. | 1 | $119.87 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 6 | $116.98 | |
| Genzyme Corporation | 4 | $98.30 | |
| Fresenius Kabi USA, LLC | 5 | $90.04 | |
| Lilly USA, LLC | 5 | $83.76 | |
| Pfizer INC. | 5 | $76.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
518
Patients
162
Total drug cost
$339,855
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 142 | 51 | $4,811 |
| Hydroxychloroquine Sulfate | Generic | 118 | 33 | $5,560 |
| Prolia (Denosumab) | Brand | 69 | 46 | $117,482 |
| Allopurinol | Generic | 41 | 0 | $609 |
| Leflunomide | Generic | 41 | 17 | $2,725 |
| Alendronate Sodium | Generic | 38 | 15 | $220 |
| Folic Acid | Generic | 17 | 0 | $54 |
| Simponi Aria (Golimumab) | Brand | 15 | 0 | $110,017 |
| Enbrel Sureclick (Etanercept) | Brand | 13 | 0 | $98,056 |
| Prednisone | Generic | 13 | 0 | $178 |
Hospital affiliations
Frequently asked questions
What is Dr. Larry Broadwell's medical specialty?
Dr. Larry Broadwell practices Rheumatology Physician in Shreveport, LA.
Where does Dr. Larry Broadwell practice?
Dr. Larry Broadwell practices at 820 Jordan St, Shreveport, LA 711014518. Office phone: 3182210399.
What is Dr. Larry Broadwell's NPI?
Dr. Larry Broadwell's National Provider Identifier (NPI) is 1326194036, issued by NPPES.
Does Dr. Larry Broadwell accept Medicare assignment?
Yes. Dr. Larry Broadwell accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Larry Broadwell commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.